Amylin analysts advise caution amid stock run-up
March 28, 2012 at 16:59 PM EDT
Amylin Pharmaceuticals analysts are advising investors to proceed with caution given Wednesday’s massive run-up in the stock on a report that Bristol-Meyers had made a bid for the company.